Northwest Biotherapeutics, Inc.
21720 23rd Drive SE
Suite 100
Bothell
Washington
98021
United States
Tel: 425-608-3000-or-877-606-9246-Toll-Free
Fax: 425-608-3026
Website: http://www.nwbio.com
About Northwest Biotherapeutics, Inc.
Northwest Biotherapeutics, Inc is a clinical stage biotechnology company focused on the development of personalized cancer vaccines designed to treat a broad range of solid tumor cancers.YEAR FOUNDED:
March 18, 1996
LEADERSHIP:
Founder: Alton Boynton
CEO: Hua Bai
CEO: Linda Powers
CTO: Marnix Bosch
CSO (Scientific): Alton Boynton
CLINICAL TRIAL:
Please click here for clinical trial information.
PRODUCTS:
All Products
FOLLOW NORTHWEST BIOTHERAPEUTICS:
Tweets by Northwest Biotherapeutics
268 articles about Northwest Biotherapeutics, Inc.
-
NW Bio Presenting At Phacilitate Immunotherapy World Forum
1/25/2016
-
NW Bio Announces Appointment Of Two New Independent Directors With Biotech/Pharma Expertise and Cybersecurity/Investigations Expertise
1/25/2016
-
NW Bio Issues Statement On Adverse Market Conditions And NW Bio Stock Decline
1/8/2016
-
NW Bio Announces Closing Of Registered Direct Offering Of $12.6 Million
12/28/2015
-
NW Bio Announces A Registered Direct Offering Of $12.6 Million
12/23/2015
-
NW Bio Announces Annual Meeting Results, Re-Election of Directors
12/21/2015
-
NW Bio Statement Regarding Appointments
12/8/2015
-
NW Bio Disregards Woodford's Choice, Brings Aboard Another Ex-FBI to Investigate Alleged Questionable Financial Dealings By CEO
12/8/2015
-
NW Bio Announces Establishment Of Special Committee And Law Firm To Conduct Independent Investigation Of Recent Allegations
12/8/2015
-
Anonymous Report Spurs Fund Manager to Call in Ex-FBI Agent to Investigate NW Bio
11/30/2015
-
NW Bio Has Entered Into An Agreement For $30 Million Of New Equity Funding From Woodford Investment Management
10/21/2015
-
NW Bio Issues Statement On Highly Unusual Trading Activity
10/20/2015
-
NW Bio Temporarily Halts Patient Screening for DCVax-L Brain Cancer Study
8/24/2015
-
Northwest Biotherapeutics Announces Data To Date From DCVax-Direct Phase I Trial
6/1/2015
-
Northwest Biotherapeutics To Present Overview Of DCVax-Direct Phase I Trial In Chicago This Weekend
5/27/2015
-
Northwest Biotherapeutics To Present At New York Academy of Sciences' Conference On Emerging Approaches To Immunotherapy
5/22/2015
-
Northwest Biotherapeutics To Webcast, Live, at VirtualInvestorConferences.com On May 7
5/7/2015
-
Northwest Biotherapeutics To Webcast, Live, At Virtualinvestorconferences.Com On May 7
5/6/2015
-
Northwest Biotherapeutics Rakes In $28.5 Million
5/1/2015
-
Northwest Biotherapeutics Featured In Presentations At The AACR Annual Meeting
4/21/2015